Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in and Associated Phenotypes

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2021 Nov 27

PMID 34828275

Citations 6

Authors

Cedrik Tekendo-Ngongang

Angela Grochowsky

Benjamin D Solomon

Sho T Yano

Affiliations

Soon will be listed here.

Abstract

(FMRP translational regulator 1) variants other than repeat expansion are known to cause disease phenotypes but can be overlooked if they are not accounted for in genetic testing strategies. We collected and reanalyzed the evidence for pathogenicity of coding, noncoding, and copy number variants published to date. There is a spectrum of disease-causing variation, with clinical and functional evidence supporting pathogenicity of five splicing, five missense, one in-frame deletion, one nonsense, and four frameshift variants. In addition, deletions occur in both mosaic full mutation patients and as constitutional pathogenic alleles. De novo deletions arise not only from full mutation alleles but also alleles with normal-sized CGG repeats in several patients, suggesting that the CGG repeat region may be prone to genomic instability even in the absence of repeat expansion. We conclude that clinical tests for potentially -related indications such as intellectual disability should include methods capable of detecting small coding, noncoding, and copy number variants.

Citing Articles

Intersection of the fragile X-related disorders and the DNA damage response.

Kumari D, Grant-Bier J, Kadyrov F, Usdin K DNA Repair (Amst). 2024; 144:103785.

PMID: 39549538 PMC: 11789500. DOI: 10.1016/j.dnarep.2024.103785.

Deciphering novel TCF4-driven mechanisms underlying a common triplet repeat expansion-mediated disease.

Bhattacharyya N, Chai N, Hafford-Tear N, Sadan A, Szabo A, Zarouchlioti C PLoS Genet. 2024; 20(5):e1011230.

PMID: 38713708 PMC: 11101122. DOI: 10.1371/journal.pgen.1011230.

The fragile X locus is prone to spontaneous DNA damage that is preferentially repaired by nonhomologous end-joining to preserve genome integrity.

Kumari D, Lokanga R, McCann C, Ried T, Usdin K iScience. 2024; 27(2):108814.

PMID: 38303711 PMC: 10831274. DOI: 10.1016/j.isci.2024.108814.

Editorial for the Fragile X Syndrome Genetics Special Issue: May 2023.

Godler D, Brown W Genes (Basel). 2023; 14(6).

PMID: 37372328 PMC: 10297929. DOI: 10.3390/genes14061148.

Emerging roles of i-motif in gene expression and disease treatment.

Luo X, Zhang J, Gao Y, Pan W, Yang Y, Li X Front Pharmacol. 2023; 14:1136251.

PMID: 37021044 PMC: 10067743. DOI: 10.3389/fphar.2023.1136251.

References

Carroll R, Shaw M, Arvio M, Gardner A, Kumar R, Hodgson B . Two novel intragenic variants in the FMR1 gene in patients with suspect clinical diagnosis of Fragile X syndrome and no CGG repeat expansion. Eur J Med Genet. 2020; 63(10):104010. DOI: 10.1016/j.ejmg.2020.104010. View

Sitzmann A, Hagelstrom R, Tassone F, Hagerman R, Butler M . Rare FMR1 gene mutations causing fragile X syndrome: A review. Am J Med Genet A. 2017; 176(1):11-18. PMC: 6697153. DOI: 10.1002/ajmg.a.38504. View

Zeidler S, Severijnen L, de Boer H, van der Toorn E, Ruivenkamp C, Bijlsma E . A missense variant in the nuclear export signal of the FMR1 gene causes intellectual disability. Gene. 2020; 768:145298. DOI: 10.1016/j.gene.2020.145298. View

Jiraanont P, Kumar M, Tang H, Espinal G, Hagerman P, Hagerman R . Size and methylation mosaicism in males with Fragile X syndrome. Expert Rev Mol Diagn. 2017; 17(11):1023-1032. PMC: 5924764. DOI: 10.1080/14737159.2017.1377612. View

Myers K, van t Hof F, Sadleir L, Legault G, Simard-Tremblay E, Amor D . Fragile Females: Case Series of Epilepsy in Girls With Disruption. Pediatrics. 2019; 144(3). DOI: 10.1542/peds.2019-0599. View

Ashkenazy H, Abadi S, Martz E, Chay O, Mayrose I, Pupko T . ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res. 2016; 44(W1):W344-50. PMC: 4987940. DOI: 10.1093/nar/gkw408. View

Parvari R, Mumm S, Galil A, Manor E, Bar-David Y, Carmi R . Deletion of 8.5 Mb, including the FMR1 gene, in a male with the fragile X syndrome phenotype and overgrowth. Am J Med Genet. 1999; 83(4):302-7. DOI: 10.1002/(sici)1096-8628(19990402)83:4<302::aid-ajmg13>3.0.co;2-p. View

Quan F, Zonana J, Gunter K, Peterson K, Magenis R, Popovich B . An atypical case of fragile X syndrome caused by a deletion that includes the FMR1 gene. Am J Hum Genet. 1995; 56(5):1042-51. PMC: 1801461. View

Gronskov K, Hjalgrim H, Bjerager M, Brondum-Nielsen K . Deletion of all CGG repeats plus flanking sequences in FMR1 does not abolish gene expression. Am J Hum Genet. 1997; 61(4):961-7. PMC: 1716002. DOI: 10.1086/514872. View

10.

Fernandez E, Rajan N, Bagni C . The FMRP regulon: from targets to disease convergence. Front Neurosci. 2013; 7:191. PMC: 3807044. DOI: 10.3389/fnins.2013.00191. View

11.

Grasso M, Faravelli F, Lo Nigro C, Chiurazzi P, Sperandeo M, Argusti A . Mosaicism for the full mutation and a microdeletion involving the CGG repeat and flanking sequences in the FMR1 gene in eight fragile X patients. Am J Med Genet. 1999; 85(3):311-6. DOI: 10.1002/(sici)1096-8628(19990730)85:3<311::aid-ajmg24>3.0.co;2-a. View

12.

Hersh J, Saul R . Health supervision for children with fragile X syndrome. Pediatrics. 2011; 127(5):994-1006. DOI: 10.1542/peds.2010-3500. View

13.

Brown W, Houck Jr G, Jeziorowska A, Levinson F, Ding X, Dobkin C . Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA. 1993; 270(13):1569-75. View

14.

Bardoni B, Sittler A, Shen Y, Mandel J . Analysis of domains affecting intracellular localization of the FMRP protein. Neurobiol Dis. 1997; 4(5):329-36. DOI: 10.1006/nbdi.1997.0142. View

15.

Rooney Riggs E, Andersen E, Cherry A, Kantarci S, Kearney H, Patel A . Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2019; 22(2):245-257. PMC: 7313390. DOI: 10.1038/s41436-019-0686-8. View

16.

Feng Y, Absher D, Eberhart D, Brown V, Malter H, Warren S . FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol Cell. 1998; 1(1):109-18. DOI: 10.1016/s1097-2765(00)80012-x. View

17.

Petek E, Kroisel P, Schuster M, Zierler H, Wagner K . Mosaicism in a fragile X male including a de novo deletion in the FMR1 gene. Am J Med Genet. 1999; 84(3):229-32. View

18.

Sievers F, Wilm A, Dineen D, Gibson T, Karplus K, Li W . Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011; 7:539. PMC: 3261699. DOI: 10.1038/msb.2011.75. View

19.

Katoh K, Aiba K, Fukushi D, Yoshimura J, Suzuki Y, Mitsui J . Clinical and molecular genetic characterization of two female patients harboring the Xq27.3q28 deletion with different ratios of X chromosome inactivation. Hum Mutat. 2020; 41(8):1447-1460. DOI: 10.1002/humu.24058. View

20.

Carion N, Briand A, Cuisset L, Pacot L, Afenjar A, Bienvenu T . Loss of the KH1 domain of FMR1 in humans due to a synonymous variant causes global developmental retardation. Gene. 2020; 753:144793. DOI: 10.1016/j.gene.2020.144793. View